PATENT CLAIM ANALYSIS

Application Number: 16212957
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-03
Patent Classification: ["424", "139100"]

Abstract:
Antibody molecules that specifically bind to APRIL are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as IgA nephropathy.

Claim (Index 8):
The antibody molecule of  claim 1 , wherein the VH comprises the amino acid sequence of SEQ ID NO: 296, and wherein the VL comprises the amino acid sequence of SEQ ID NO: 286.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 98.0
- Lexical Diversity: 1.2
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14307519', '15604556', '15390067', '15818090', '15258925']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8406379913913624
- 35 USC 102 Novelty (BERT): 0.6061230739638
- Combined Prediction Score: 0.8171864996486062
- Mean Citation Score: 576.878328
- Max Citation Score: 591.8777
- Similarity Product: 465.7863360355735

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test